The general picture of uremia

Seminars in Dialysis

Volumn 22, Issue 4, 2009, Pages 329-333

  Almeras, Cyrielle ^a   Argilés, Àngel ^a,b,c  

^a UNIV MONTPELLIER   (France)

^b Centre de Dialyse Néphrologie Dialyse St Guilhem   (France)

^c RD Néphrologie SAS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; HUMAN; PATHOPHYSIOLOGY; UREMIA;

HUMANS; UREMIA;

EID: 69249142202     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2009.00575.x     Document Type: Article

References (33)

1. Bernard C : Leçons sur les Phénomènes de Ia Vie Commune aux Animaux et aux Végétaux, 1, Paris, France : Baillière, 1878.
2. Peters JP : Body Water. London, UK : Baillière, Tindall and Cox, 1935.
3. Piorry PA, L'Héritier D : Traité d'Alterations du Sang. Paris, France : Baillière, 1840.
4. Wills MR : Uremic toxins, and their effect on intermediary metabolism. Clin Chem, 31 : 5 13, 1985
5. Vanholder R, De Smet R, Glorieux G, Argilés A, Baurmeister U, Brunet P, Clark W, Cohen G, De Deyn PP, Deppisch R, Descamps-Latscha B, Henle T, Jörres A, Lemke Hd, Massy ZA, Passlick-Deetjen J, Rodriguez M, Stegmayr B, Stenvinkel P, Tetta C, Wanner C, Zidek W : Review on uremic toxins: classification, concentration and interindividual variability. Kidney Int 63 : 1934 1943, 2003
6. Vanholder R, Van Laecke S, Glorieux G : What is new in uremic toxicity? Pediatr Nephrol 23 : 1211 1221, 2008
7. Maher JF, Schreiner GE, Waters TJ : Successful intermittent hemodialysis - longest reported maintenance of life in true oliguria (181 days). Trans Am Soc Artif Intern Organs 6 : 123, 1960
8. Schribner BH, Buri R, Caner JEZ, Hegstrom R, Burnell JM : The treatment of chronic uremia by means of intermittent hemodialysis: a preliminary report. Trans Am Soc Artif Intern Organs 6 : 114 121, 1960
9. Welt LG, Smith EKM, Dunn MJ, Czerwinski A, Proctor H, Cole C, Balfe JW, Gittelman HJ : Membrane transport defect: the sick cell. Trans Assoc Am Physicians 80 : 21, 1967
10. Bush A : The lung in uremia. Sem Respir Med 9 : 273, 1988
11. Mitch WE, Wilcox CS : Disorders of body fluids, sodium and potassium in chronic renal failure. Am J Med 72 : 536, 1982
12. Blumle CW, Potter HP, Elkington JR : Changes in body composition in acuter renal failure. J Clin Invest 35 : 1094, 1951
13. Acosta JH : Hypertension in chronic renal disease. Kidney Int 22 : 702, 1982
14. Blythe WB : Natural history of hypertension in renal parenchymal diseae. Am J Kidney Dis 5 : A50, 1985
15. Heiland A, Heidbreder E : Retinopathy in hypertension; increased incidence in renoprenchimal disease. Contrib Nephrol 54 : 144, 1987
16. Vanholder R, Massy Z, Argilés A, Spasovski G, Verbecke F, Lameire N, for the European Uremic Toxin Work Group (EUTox) : Chronic kidney disease as cause of cardiovascular morbidity and mortality. Nephrol Dial Transpl 20 : 1048 1056, 2005
17. Foley RN, Parfrey PS, Sarnak MJ : Clinical epidemiology of cardio-vascular disease in chronic renal failure. Am J Kidney Dis 32 (Suppl. 5 S112 S119, 1998.
18. Lidner A, Charra B, Sherrard D, Schribner BH : Accelerated atherosclerosis in prolonged maintenance haemodialysis. N Engl J Med 290 : 697 701, 1974
19. Muntner P, He J, Astor BC, Folsom AR, Coresh J : Traditional and nontraditional risk factors predict coronary heart disease in chronic kidney disease: results from the atherosclerosis risk in communities study. J Am Soc Nephrol 16 : 529 538, 2005
20. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, Teehan BP, Levey AS : The Hemodialysis (HEMO) Study. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 58 : 353 362, 2000
21. Stenvinkel P, Carrero JJ, Axelsson J, Lindholm B, Heimbürger O, Massy Z : Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle? Clin J Am Soc Nephrol 3 : 505 521, 2008
22. Rao DS, Shih MS, Mohini R : Effect of serum parathyroid hormone and bone marrow fibrosis on the response to erythropoietin in uremia. N Engl J Med 328 : 171 175, 1993
23. Yasunaga C, Matsuo K, Yanagida T, Matsuo S, Nakamoto M, Goya T : Early effects of parathyroidectomy on erythropoietin production in secondary hyperparathyroidism. Am J Surg 183 : 199 204, 2002
24. Argilés A, Lorho R, Mourad G, Mion CM : High dose alfacalcidol for anemia in dialysis. Lancet 342 : 378 379, 1993
25. Argilés A, Mourad G, Lorho R, Kerr PG, Flavier JL, Canaud B, Mion CM : Medical treatment of severe hyperparathyroidism and its influence on anemia in end stage chronic renal failure. Nephrol Dial Transpl 9 : 1809 1812, 1994
26. Pecoits-Filho R, Lindholm B, Stenvinkel P : The malnutrition, inflammation, and atherosclerosis (MIA) syndrome - the heart of the matter. Nephrol Dial Transpl 17 : 28 31, 2002
27. Argilés A, Frapier JM, Lorho R, Servel MF, Garrigue V, Canet S, Chong G, Albat B, Mourad G : Life-threatening vascular complications of severe hyperphosphatemia. Nephrol Dial Transpl 18 : 201 205, 2003
28. Kong NCT, Beran J, Kee SA, Miguel JL, Sanchez C, Bayas J-M, Vilella A, Calbo-Torrecillas F, Lopez de Novales E, Srinivasa K, Stoffel M, Hoet B : A new adjuvant improves the immune response to hepatitis B vaccine in hemodialysis patients. Kidney Int 73 : 856 862, 2007
29. Paul Martin, Friedman LS : Chronic viral hepatitis and the management of chronic renal failure. Kidney Int 47 : 1231 1241, 1995
30. Eleftheriadis T, Antoniadi G, Liakopoulos V, Kartsios C, Stefanidis I : Disturbances of acquired immunity in hemodialysis patients. Semin Dial 20 : 440 451, 2007
31. Girndt M, Sester M, Sester U, Kaul H, Köhler H : Molecular aspects of T- and B-cell function in uremia. Kidney Int 78 (Suppl. S206 S211, 2001
32. Descamps-Latschka B : The immune system in end-stage renal disease. Curr Opin Nephrol Hypertens 2 : 883 889, 1993
33. Teschan PE, Ginn HE, Bourne JR, Ward JW, Hamel B, Nunnally JC, Musso M, Vaughn WK : Quantitative indices of clinical uremia. Kidney Int 15 : 676 697, 1979